Portfolio Manager Factsheet

October 2017

Chugai Pharmaceutical. reached new highs after a broker upgrade and a solid earnings report. Celgene lost one-third of its market cap during the month due to a patent expiration, unexpected announcement of discontinuation of a high profile late stage clinical asset, and also lowered long term guidance during their quarterly earnings report.  

Read more »

Register for email alerts

Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.